Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1249134c120f28253af6826ae8ac9156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca0cf1ac677a099e9f3246185341b4f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db0e8dfd9f9549a2e21cdb3342d5de5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46dd4b4938bdc66938d8b5a2c84bac1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae8b3fd2a75da9bad15bc5e651926228 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8281 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8249 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8263 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8279 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8257 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-82 |
filingDate |
2003-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9596d2ab0647953407d32c668ac17c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bfa107488248380002d2c50b31b9d73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22d26187d9ede44e80a2fd6c4cae4fa0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3381493e95b16d42d8d8a1177bb04fd9 |
publicationDate |
2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004016745-A2 |
titleOfInvention |
Backterial effector proteins which inhibit programmed cell death |
abstract |
The present invention relates to a bacterial effector protein which inhibits programmed cell death in eukaryotes and a nucleic acid molecule encoding such a protein. The present invention also relates to methods of suppressing programmed cell death in eukaryotes, delaying senescence in plants, and increasing protein expression in plants. The present invention further relates to a nucleic acid construct having a nucleic acid molecule encoding a first protein, which suppresses immunity by inhibition of programmed cell death in eukaryotes, coupled to a nucleic acid molecule encoding a second protein which is toxic when expressed in eukaryotes. Additionally, the present invention provides a method of stabilizing a transgenic plant transformed with such a nucleic acid construct. Finally, the present invention provides a method of treating subjects for a condition mediated by programmed cell death involving administering to the subject a bacterial effector protein which inhibits programmed cell death. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111713204-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2666865-A3 |
priorityDate |
2002-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |